Compare · BCPC vs DD
BCPC vs DD
Side-by-side comparison of Balchem Corporation (BCPC) and DuPont de Nemours Inc. (DD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BCPC and DD operate in Major Chemicals (Industrials), so they compete in similar markets.
- DD is the larger of the two at $19.20B, about 3.7x BCPC ($5.14B).
- Over the past year, BCPC is down 5.2% and DD is down 31.7% - BCPC leads by 26.5 points.
- DD has been more active in the news (18 items in the past 4 weeks vs 1 for BCPC).
- DD has more recent analyst coverage (25 ratings vs 7 for BCPC).
- Company
- Balchem Corporation
- DuPont de Nemours Inc.
- Price
- $159.27-0.25%
- $46.81-0.06%
- Market cap
- $5.14B
- $19.20B
- 1M return
- -0.19%
- -3.23%
- 1Y return
- -5.20%
- -31.69%
- Industry
- Major Chemicals
- Major Chemicals
- Exchange
- NASDAQ
- NYSE
- IPO
- 2017
- News (4w)
- 1
- 18
- Recent ratings
- 7
- 25
Balchem Corporation
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions; and human grade choline nutrients and mineral amino acid chelated products for wellness applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.
DuPont de Nemours Inc.
DuPont de Nemours, Inc. provides technology-based materials, ingredients, and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. The company's Electronics & Imaging segment supplies materials to manufacture photovoltaics and solar cells; materials and printing systems to the advanced printing industry; and materials and solutions for the fabrication of semiconductors and integrated circuits addressing front-end and back-end of the manufacturing process. This segment also provides semiconductor and advanced packaging materials; dielectric and metallization solutions for chip packaging; and silicones for light emitting diode packaging and semiconductor applications; permanent and process chemistries for the fabrication of printed circuit boards to include laminates and substrates, electroless, and electrolytic metallization solutions, as well as patterning solutions, and materials and metallization processes for metal finishing, decorative, and industrial applications. In addition, it offers various materials to manufacture rigid and flexible displays for liquid crystal displays, advanced-matrix organic light emitting diode, and quantum dot applications. The Transportation & Advanced Polymers segment provides engineering resins, adhesives, silicones, lubricants, and parts to engineers and designers in the transportation, electronics, healthcare, industrial, and consumer end-markets. Its Safety & Construction segment provides engineered products and integrated systems for worker safety, water purification and separation, aerospace, energy, medical packaging, and building materials. The company was formerly known as DowDuPont Inc. and changed its name to DuPont de Nemours, Inc. in June 2019. DuPont de Nemours, Inc. is based in Wilmington, Delaware.
Latest BCPC
- Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026
- SEC Form 10-Q filed by Balchem Corporation
- Balchem Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Balchem Corporation Reports First Quarter 2026 Financial Results
- SEC Form SCHEDULE 13G filed by Balchem Corporation
- SEC Form DEF 14A filed by Balchem Corporation
- SEC Form DEFA14A filed by Balchem Corporation
- Balchem Corporation Releases 2025 Sustainability Report
- Balchem Corporation Announces Quarterly Conference Call for First Quarter 2026 Financial Results on April 30, 2026
- SEC Form 3 filed by new insider Gilson Erin Leigh
Latest DD
- CEO Koch Lori covered exercise/tax liability with 4,673 shares and sold $12,741 worth of shares (261 units at $48.82), decreasing direct ownership by 1% to 345,172 units (SEC Form 4)
- SVP & CFO Franzen Antonella B covered exercise/tax liability with 1,558 shares, decreasing direct ownership by 2% to 68,809 units (SEC Form 4)
- Director Macpherson Donald G was granted 671 shares, increasing direct ownership by 13% to 5,868 units (SEC Form 4)
- Director Lowery Frederick M. was granted 800 shares, increasing direct ownership by 2% to 40,205 units (SEC Form 4)
- Director Cutler Alexander M was granted 1,033 shares, increasing direct ownership by 1% to 81,794 units (SEC Form 4)
- SEC Form SD filed by DuPont de Nemours Inc.
- Director Breen Edward D was granted 4,030 shares, increasing direct ownership by 1% to 278,008 units (SEC Form 4)
- Director Macpherson Donald G was granted 4,030 shares, increasing direct ownership by 345% to 5,197 units (SEC Form 4)
- Director Mcmaken Kurt B was granted 4,030 shares, increasing direct ownership by 95% to 8,258 units (SEC Form 4)
- Director Lowery Frederick M. was granted 4,030 shares, increasing direct ownership by 11% to 39,405 units (SEC Form 4)